infinite-dataset-hub/AspirinComposition

--- license: mit tags: - infinite-dataset-hub - synthetic --- # AspirinComposition tags: chemical_properties, drug_formulation, medical_use _Note: This is an AI-generated dataset so its content may be inaccurate or false_ **Dataset Description:** The dataset titled 'AspirinComposition' comprises detailed entries of various studies, research papers, and articles that focus on the composition, chemical properties, drug formulation, and medical use of Aspirin. The entries are meticulously curated to offer insights into the biochemical aspects, formulation techniques, therapeutic applications, and clinical outcomes associated with Aspirin. **CSV Content Preview:** ``` label,Title,Abstract,Year,Keyword Chemical Composition,"Detailed Analysis of Aspirin's Salicylate Content","This study explores the precise chemical composition of Aspirin, focusing on the percentage of salicylate and other constituents.","2020","Chemical Composition" Formulation Techniques,"Innovative Formulation Methods for Aspirin Enhancement","Research presented in this paper discusses new techniques for formulating Aspirin to improve its bioavailability and efficacy.","2019","Formulation Techniques" Medical Application,"Aspirin in Cardiovascular Prevention","A comprehensive review of Aspirin's role in preventing cardiovascular diseases, highlighting its benefits and limitations.","2021","Medical Use" Clinical Outcomes,"Aspirin Therapy in Acute Ischemic Stroke Patients","An examination of the outcomes of Aspirin therapy in patients who have suffered an acute ischemic stroke.","2018","Clinical Outcomes" Bioavailability,"Assessment of Aspirin Bioavailability in Various Populations","This research assesses the bioavailability of Aspirin across different population groups, considering factors such as age and health status.","2022","Bioavailability" ``` **Source of the data:** The dataset was generated using the [Infinite Dataset Hub](https://huggingface.co/spaces/infinite-dataset-hub/infinite-dataset-hub) and microsoft/Phi-3-mini-4k-instruct using the query 'Aspirin': - **Dataset Generation Page**: https://huggingface.co/spaces/infinite-dataset-hub/infinite-dataset-hub?q=Aspirin&dataset=AspirinComposition&tags=chemical_properties,+drug_formulation,+medical_use - **Model**: https://huggingface.co/microsoft/Phi-3-mini-4k-instruct - **More Datasets**: https://huggingface.co/datasets?other=infinite-dataset-hub--- 许可证：MIT 标签： - 无限数据集中心（Infinite Dataset Hub） - 合成数据集 --- # AspirinComposition 标签：化学性质、药物制剂、医疗用途 *注：本数据集由人工智能生成，其内容可能存在不准确或错误之处。* **数据集描述：** 本名为AspirinComposition的数据集包含聚焦于阿司匹林（Aspirin）的组成、化学性质、药物制剂以及医疗用途的各类研究、学术论文与文章的详细条目。这些条目经过精心整理，旨在提供关于阿司匹林的生化特性、制剂工艺、治疗应用与临床结局的深入洞察。 **CSV内容预览：** 标签,标题,摘要,年份,关键词 化学组成（Chemical Composition）,"阿司匹林水杨酸酯含量的详细分析","本研究探讨了阿司匹林的精确化学组成，重点关注其水杨酸酯及其他成分的占比。","2020","化学组成（Chemical Composition）" 制剂工艺（Formulation Techniques）,"用于提升阿司匹林性能的创新制剂方法","本文呈现的研究讨论了用于改善阿司匹林生物利用度与疗效的新型制剂技术。","2019","制剂工艺（Formulation Techniques）" 医疗应用（Medical Application）,"阿司匹林在心血管疾病预防中的应用","本综述全面探讨了阿司匹林在预防心血管疾病中的作用，重点阐述其获益与局限性。","2021","医疗用途（Medical Use）" 临床结局（Clinical Outcomes）,"急性缺血性卒中患者的阿司匹林治疗结局","本研究考察了急性缺血性卒中患者接受阿司匹林治疗后的临床结局。","2018","临床结局（Clinical Outcomes）" 生物利用度（Bioavailability）,"不同人群的阿司匹林生物利用度评估","本研究评估了不同人群群体中阿司匹林的生物利用度，考虑了年龄与健康状况等因素。","2022","生物利用度（Bioavailability）" **数据来源：** 本数据集通过[无限数据集中心（Infinite Dataset Hub）](https://huggingface.co/spaces/infinite-dataset-hub/infinite-dataset-hub)与Microsoft/Phi-3-mini-4k-instruct模型，以查询词「Aspirin」生成： - **数据集生成页面**：https://huggingface.co/spaces/infinite-dataset-hub/infinite-dataset-hub?q=Aspirin&dataset=AspirinComposition&tags=chemical_properties,+drug_formulation,+medical_use - **模型**：https://huggingface.co/microsoft/Phi-3-mini-4k-instruct - **更多数据集**：https://huggingface.co/datasets?other=infinite-dataset-hub